HOME >> BIOLOGY >> NEWS
Molecular traffic cop directs cellular signals

Scientists report that a recently identified molecule functions as a molecular switch that influences the activity of key signaling molecules by restricting the location of the activated molecules within the cell. The research, published in the July issue of Developmental Cell, provides new insight into how a widely used signaling cascade can be spatially regulated to enhance the specificity of cellular responses.

The Ras/ERK MAP kinase signaling cascade is activated by many extracellular stimuli and is critical to a variety of cellular processes. The molecules that make up this cascade are present in different subcellular compartments and exactly where the cascade is activated depends on the extracellular stimulus. ERK activity can influence molecules in the cell cytoplasm or it can influence whether target genes in the nucleus are turned on or off. It is not known exactly how a particular stimulus can confine Ras/ERK MAP activity to a specific region of the cell.

A molecule called hSef was recently identified as an inhibitor of this cascade but the molecular mechanisms of inhibition are unclear. Dr. Eisuke Nishida from The Department of Cell and Developmental Biology at Kyoto University in Japan examined exactly how hSef influences Ras/ERK MAP kinase signaling in the cytoplasm and nucleus. When cells were stimulated with a common growth factor, hSef interacted with activated ERK in the cytoplasm. The inhibitor was only switched on when the Ras/ERK MAP kinase pathway was activated. Interestingly, activated hSef works not by directly inhibiting the activity of ERK, but by preventing activated ERK from entering the nucleus. When hSef levels were experimentally reduced, stimulus-dependant ERK activation in the nucleus increased dramatically.

These results demonstrate that the newly discovered inhibitor hSef is a signaling-dependent regulator of the Ras/ERK MAP kinase cascade that blocks MAP kinase influence on target genes by res
'"/>

Contact: Heidi Hardman
hhardman@cell.com
617-397-2879
Cell Press
12-Jul-2004


Page: 1 2

Related biology news :

1. Molecular motor implicated in tissue remodeling
2. 16th EORTC NCI AACR Symposium Molecular Targets and Cancer Therapeutics
3. 16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
4. Molecular staples shape a cancer killer
5. Molecular motor myosin VI moves hand over hand, researchers say
6. Molecular therapeutics advance fight against brain cancer
7. Molecular motor shuttles key protein in response to light
8. Molecular marker predicts success of breast cancer treatment
9. Molecular image of genotoxin reveals how bacteria damage human DNA
10. Molecular mechanism found that may improve ability of stem cells to fight disease
11. Molecular midwives hold clues to the origin of life

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: